tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Berens, 154 are a BUY (68.75%), 49 are a HOLD (21.88%), 21 are a SELL (9.38%).
Analyst Andrew Berens, currently employed carries an average stock price target met ratio of 55.19% that have a potential upside of 31.71% achieved within 226 days. Previously, Andrew Berens worked at LEERINK.
Andrew Berens’s has documented 440 price targets and ratings displayed on 38 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on ZYME, Zymeworks . Common Stock at 07-Nov-2024.
Analyst best performing recommendations are on ELEV (ELEVATION ONCOLOGY).
The best stock recommendation documented was for ELEV (ELEVATION ONCOLOGY) at 1/9/2023. The price target of $1 was fulfilled within 3 days with a profit of $0.2 (25%) receiving and performance score of 83.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$75
$36.03 (92.46%)
$53
9 days ago
(09-Dec-2024)
6/7 (85.71%)
$24.17 (47.55%)
477
Buy
$56
$17.03 (43.70%)
$37
2 months 21 days ago
(27-Sep-2024)
9/12 (75%)
$10.39 (22.78%)
227
Hold
$46
$7.03 (18.04%)
$30
6 months 5 days ago
(13-Jun-2024)
4/4 (100%)
$-0.77 (-1.65%)
169
Hold
$53
$14.03 (36.00%)
$33
6 months 14 days ago
(04-Jun-2024)
8/8 (100%)
$5.65 (11.93%)
164
Buy
$42
$3.03 (7.78%)
$67
1 years 5 months 21 days ago
(27-Jun-2023)
6/12 (50%)
$13.87 (49.31%)
234
Which stock is Andrew Berens is most bullish on?
Which stock is Andrew Berens is most reserved on?
What Year was the first public recommendation made by Andrew Berens?
